Daniel J. Toft

1.4k total citations
22 papers, 1.0k citations indexed

About

Daniel J. Toft is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Biomaterials. According to data from OpenAlex, Daniel J. Toft has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Biomaterials. Recurrent topics in Daniel J. Toft's work include RNA Interference and Gene Delivery (5 papers), Supramolecular Self-Assembly in Materials (5 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). Daniel J. Toft is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Supramolecular Self-Assembly in Materials (5 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). Daniel J. Toft collaborates with scholars based in United States, Australia and Italy. Daniel J. Toft's co-authors include Vincent L. Cryns, Samuel I. Stupp, Tyson J. Moyer, Stephany M. Standley, Stephen Soukasene, Daniel I. H. Linzer, Feng Chen, Joel A. Finbloom, Hyung‐Kun Lee and Vimla Band and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and ACS Nano.

In The Last Decade

Daniel J. Toft

19 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel J. Toft United States 13 628 572 235 118 116 22 1.0k
Jinhe Pan Canada 19 387 0.6× 184 0.3× 235 1.0× 109 0.9× 286 2.5× 37 1.2k
Dirk Finsinger Germany 12 645 1.0× 185 0.3× 209 0.9× 228 1.9× 154 1.3× 17 1.2k
James L. LaBelle United States 15 607 1.0× 222 0.4× 128 0.5× 70 0.6× 208 1.8× 47 1.0k
Vladimir G. Omelyanenko United States 13 709 1.1× 466 0.8× 122 0.5× 199 1.7× 120 1.0× 21 1.2k
Kanya Rajangam United States 11 500 0.8× 458 0.8× 180 0.8× 98 0.8× 252 2.2× 23 1.0k
Ran Lin United States 17 650 1.0× 795 1.4× 291 1.2× 326 2.8× 77 0.7× 21 1.1k
Regine Peschka‐Süss Germany 15 869 1.4× 504 0.9× 191 0.8× 273 2.3× 73 0.6× 20 1.4k
David G. Leach United States 10 282 0.4× 334 0.6× 174 0.7× 258 2.2× 133 1.1× 14 877
Xishan Chen China 18 601 1.0× 266 0.5× 64 0.3× 202 1.7× 211 1.8× 32 1.0k
Rami W. Chakroun United States 12 430 0.7× 592 1.0× 178 0.8× 422 3.6× 84 0.7× 13 961

Countries citing papers authored by Daniel J. Toft

Since Specialization
Citations

This map shows the geographic impact of Daniel J. Toft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Toft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Toft more than expected).

Fields of papers citing papers by Daniel J. Toft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Toft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Toft. The network helps show where Daniel J. Toft may publish in the future.

Co-authorship network of co-authors of Daniel J. Toft

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Toft. A scholar is included among the top collaborators of Daniel J. Toft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Toft. Daniel J. Toft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toft, Daniel J.. (2022). Abstract #1177032: A Rare Presentation of Hypoglycemia After Pancreas-Kidney Transplant. Endocrine Practice. 28(5). S30–S30.
2.
Toft, Daniel J.. (2021). A Third of >1000 Patients Treated for Hypothyroidism May Not Require Thyroid Hormone Therapy. Clinical Thyroidology. 33(1). 14–16. 1 indexed citations
3.
Toft, Daniel J.. (2020). A Change in Levothyroxine Manufacturer Frequently Results in Abnormal Serum Thyroid Function Tests. Clinical Thyroidology. 32(5). 211–213. 2 indexed citations
5.
Toft, Daniel J.. (2019). Radioactive Iodine Therapy for Hyperthyroidism Is Associated with Increased Solid Cancer Mortality. Clinical Thyroidology. 31(8). 326–329. 1 indexed citations
6.
Toft, Daniel J.. (2019). Glucagon-like Peptide 1 Receptor Agonists Do Not Alter Calcitonin Levels in Humans. Clinical Thyroidology. 31(6). 253–255.
7.
Moyer, Tyson J., Feng Chen, Daniel J. Toft, et al.. (2019). Self-Assembled Peptide Nanostructures Targeting Death Receptor 5 and Encapsulating Paclitaxel As a Multifunctional Cancer Therapy. ACS Biomaterials Science & Engineering. 5(11). 6046–6053. 24 indexed citations
8.
Leung, Angela M., Andrew J. Bauer, Salvatore Benvenga, et al.. (2017). American Thyroid Association Scientific Statement on the Use of Potassium Iodide Ingestion in a Nuclear Emergency. Thyroid. 27(7). 865–877. 13 indexed citations
9.
Toft, Daniel J., Miles Fuller, Matthew J. Schipma, et al.. (2016). αB-crystallin and HspB2 deficiency is protective from diet-induced glucose intolerance. Genomics Data. 9. 10–17. 4 indexed citations
10.
Moyer, Tyson J., Joel A. Finbloom, Feng Chen, et al.. (2014). pH and Amphiphilic Structure Direct Supramolecular Behavior in Biofunctional Assemblies. Journal of the American Chemical Society. 136(42). 14746–14752. 173 indexed citations
11.
Soukasene, Stephen, Daniel J. Toft, Tyson J. Moyer, et al.. (2011). Antitumor Activity of Peptide Amphiphile Nanofiber-Encapsulated Camptothecin. ACS Nano. 5(11). 9113–9121. 216 indexed citations
12.
Standley, Stephany M., Daniel J. Toft, Hao Cheng, et al.. (2010). Induction of Cancer Cell Death by Self-assembling Nanostructures Incorporating a Cytotoxic Peptide. Cancer Research. 70(8). 3020–3026. 178 indexed citations
13.
Toft, Daniel J. & Vincent L. Cryns. (2010). Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies. Endocrine Reviews. 31(5). 776–777. 3 indexed citations
14.
Layden, Brian T., et al.. (2009). Primary CNS lymphoma with bilateral symmetric hypothalamic lesions presenting with panhypopituitarism and diabetes insipidus. Pituitary. 14(2). 194–197. 15 indexed citations
15.
Toft, Daniel J., et al.. (2001). Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression. Proceedings of the National Academy of Sciences. 98(23). 13055–13059. 67 indexed citations
16.
Toft, Daniel J. & Daniel I. H. Linzer. (2000). Identification of Three Prolactin-Related Hormones as Markers of Invasive Trophoblasts in the Rat1. Biology of Reproduction. 63(2). 519–525. 22 indexed citations
17.
Toft, Daniel J. & Daniel I. H. Linzer. (1999). Prolactin (PRL)-Like Protein J, a Novel Member of the PRL/Growth Hormone Family, Is Exclusively Expressed in Maternal Decidua1. Endocrinology. 140(11). 5095–5101. 19 indexed citations
18.
Toft, Daniel J.. (1999). Prolactin (PRL)-Like Protein J, a Novel Member of the PRL/Growth Hormone Family, Is Exclusively Expressed in Maternal Decidua. Endocrinology. 140(11). 5095–5101. 8 indexed citations
19.
Ajtai, Katalin, Daniel J. Toft, & Thomas P. Burghardt. (1994). Path and Extent of Cross-Bridge Rotation during Muscle Contraction. Biochemistry. 33(18). 5382–5391. 14 indexed citations
20.
Ajtai, Katalin, et al.. (1992). Stereospecific reaction of muscle fiber proteins with the 5' or 6' isomer of (iodoacetamido)tetramethylrhodamine. Biochemistry. 31(49). 12431–12440. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026